Investor Update

Basel, 19 July 2011

Anti-Human IL-6 Receptor Monoclonal Antibody "Actemra" Subcutaneous Injection Demonstrates Efficacy in Rheumatoid Arthritis in Phase III Clinical Study

Dear Investor,

Please find attached a press release by Chugai.

Do not hesitate to contact us for any further questions.